LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 39 filers reported holding LARIMAR THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $969 | +10.0% | 245,342 | -12.9% | 0.00% | +100.0% |
| Q2 2023 | $881 | +6.4% | 281,574 | +54.1% | 0.00% | 0.0% |
| Q1 2023 | $828 | -12.4% | 182,742 | -20.1% | 0.00% | 0.0% |
| Q4 2022 | $945 | -99.9% | 228,774 | -22.8% | 0.00% | 0.0% |
| Q3 2022 | $948,000 | +175.6% | 296,367 | +68.8% | 0.00% | – |
| Q2 2022 | $344,000 | -50.9% | 175,542 | +1.6% | 0.00% | -100.0% |
| Q1 2022 | $700,000 | -66.3% | 172,742 | -10.4% | 0.00% | -66.7% |
| Q4 2021 | $2,080,000 | -26.8% | 192,774 | -21.7% | 0.00% | -25.0% |
| Q3 2021 | $2,840,000 | +47.7% | 246,274 | +25.8% | 0.00% | +100.0% |
| Q2 2021 | $1,923,000 | -38.0% | 195,774 | -7.9% | 0.00% | -50.0% |
| Q1 2021 | $3,104,000 | -34.5% | 212,474 | -4.0% | 0.00% | -20.0% |
| Q4 2020 | $4,740,000 | +57.0% | 221,374 | +11.2% | 0.01% | +66.7% |
| Q3 2020 | $3,020,000 | +12.7% | 199,074 | -4.6% | 0.00% | +50.0% |
| Q2 2020 | $2,680,000 | – | 208,574 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,746,265 | $12,440,580 | 3.30% |
| Opaleye Management Inc. | 1,401,000 | $6,346,530 | 1.90% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,941,357 | $76,744,347 | 1.71% |
| GREAT POINT PARTNERS LLC | 900,000 | $4,077,000 | 0.80% |
| DAFNA Capital Management LLC | 236,873 | $1,073,035 | 0.32% |
| Perceptive Advisors | 2,280,709 | $10,331,612 | 0.30% |
| Atlas Venture Advisors, Inc. | 292,184 | $1,323,594 | 0.28% |
| MANGROVE PARTNERS IM, LLC | 805,815 | $3,650,342 | 0.24% |
| Verition Fund Management LLC | 1,938,822 | $8,782,864 | 0.12% |
| Woodline Partners LP | 1,681,913 | $7,619,066 | 0.10% |